UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder

Summary

UNLOCKED: A Phase 2 Trial to Evaluate the Efficacy and Safety of KB195 in Subjects with a Urea Cycle Disorder with Inadequate Control on Standard of Care

Timeline

Start

2019-09-17

Primary completion

2021-02-02

Completion

2021-03-02

Outcome

Outcome not reported

Stopped (Business): “Kaleido Biosciences, Inc. closed the K020-218 trial due to business reasons, and not due to any safety concerns.”

Drugs

Indications